December 22, 2016 News by Alexandra Andersson, PhD Cures Act May Speed Approval of Stem Cell Therapies for MS and Other Diseases The 21st Century Cures Act, recently signed into law by President Barack Obama, includes provisions that aim to speed up the process by which the U.S. Food and Drug Administration (FDA) reviews stem cell treatments for patients with degenerative diseases, such as multiple sclerosis, rheumatoid arthritis, and Parkinson’s disease. This act also…
October 12, 2016 News by Alexandra Andersson, PhD Potential Therapy, Laquinimod, Shows Promise as Progressive MS Treatment in Mouse Study The experimental therapy laquinimod was seen to prevent the start of harmful immune responses and to disrupt the progression of multiple sclerosis (MS) in a mouse model of the disease. This finding may be especially promising, as the treatment is being developed for people with both relapsing MS and its rarer…
